Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome

Journal of Clinical Immunology

Volumn 30, Issue 2, 2010, Pages 241-252

  Guo, Min ^a   Mao, Xiaobo ^a   Ji, Qingwei ^a   Lang, Mingjian ^b   Li, Songnan ^a   Peng, Yudong ^a   Zhou, Wei ^a   Xiong, Bo ^a   Zeng, Qiutang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Acute coronary syndrome; Atherosclerosis; Inflammation; IRF 1; Th1

Indexed keywords

INTERFERON REGULATORY FACTOR 1;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CELL FUNCTION; CHRONIC INFLAMMATION; FEMALE; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; TH1 CELL;

ACUTE CORONARY SYNDROME; AGED; ANTIGENS, CD4; CELL DIFFERENTIATION; CELLS, CULTURED; CHEST PAIN; CYTOKINES; ELECTROCARDIOGRAM PATTERN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERLEUKIN-12; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-12; RNA, SMALL INTERFERING; TH1 CELLS;

EID: 77953540057     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9367-8     Document Type: Article

References (41)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695
2. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol. 2006;26:2421-2432
3. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874
4. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK. Expression of class ii transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest. 1985;76:125-131
5. Roselaar SE, Kakkanathu PX, Daugherty A. Lymphocyte populations in atherosclerotic lesions of apoe-/- and ldl receptor-/- mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol. 1996;16:1013-1018
6. Methe H, Brunner S, Wiegand D, Nabauer M, Koglin J, Edelman ER. Enhanced t-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol. 2005;45:1939-1945
7. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145:33-43.
8. Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, Bariety J, et al. In vivo downregulation of t helper cell 1 immune responses reduces atherogenesis in apolipoprotein e-knockout mice. Circulation. 2001;104:197-202.
9. Fisher M, Folland E. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences. Am J Ther. 2008;15:137-149
10. Cheng X, Liao YH, Ge H, Li B, Zhang J, Yuan J, et al. Th1/th2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol. 2005;25:246-253
11. Ji QW, Guo M, Zheng JS, Mao XB, Peng YD, Li SN, et al. Downregulation of t helper cell type 3 in patients with acute coronary syndrome. Arch Med Res. 2009;40:285-293
12. Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, et al. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:1474-1478
13. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, et al. Overexpression of interleukin-10 by activated t lymphocytes inhibits atherosclerosis in ldl receptordeficient mice by altering lymphocyte and macrophage phenotypes. Circ Res. 2002;90:1064-1071
14. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, et al. Increased th1 activity in patients with coronary artery disease. Cytokine. 2004;26:131-137
15. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the t-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135-2139
16. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein e knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:2137-2142
17. Sato M, Taniguchi T, Tanaka N. The interferon system and interferon regulatory factor transcription factors - studies from gene knockout mice. Cytokine Growth Factor Rev. 2001;12:133-142
18. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, et al. Targeted disruption of irf-1 or irf-2 results in abnormal type i ifn gene induction and aberrant lymphocyte development. Cell. 1993;75:83-97.
19. Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, et al. Requirement for irf-1 in the microenvironment supporting development of natural killer cells. Nature. 1998;391:700-703
20. Coccia EM, Stellacci E, Valtieri M, Masella B, Feccia T, Marziali G, et al. Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation. Biochem J. 2001;360: 285-294
21. Tada Y, Ho A, Matsuyama T, Mak TW. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J Exp Med. 1997;185:231-238
22. Buch T, Uthoff-Hachenberg C, Waisman A. Protection from autoimmune brain inflammation in mice lacking IFN-regulatory factor-1 is associated with Th2-type cytokines. Int Immunol. 2003;15:855-859
23. Sommer F, Faller G, Rollinghoff M, Kirchner T, Mak TW, Lohoff M. Lack of gastritis and of an adaptive immune response in interferon regulatory factor-1-deficient mice infected with helicobacter pylori. Eur J Immunol. 2001;31:396-402.
24. Nakazawa T, Satoh J, Takahashi K, Sakata Y, Ikehata F, Takizawa Y, et al. Complete suppression of insulitis and diabetes in nod mice lacking interferon regulatory factor-1. J Autoimmun. 2001;17:119-125
25. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 1997;6:673-679
26. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M, et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 1997;6:681-689 (Pubitemid 27305731)
27. Unutmaz D, Vilcek J. IRF1: a deus ex machina in Th1 differentiation. Nat Immunol. 2008;9:9-10.
28. Falk E. Coronary thrombosis: pathogenesis and clinical manifestations. Am J Cardiol. 1991;68:28B-35.
29. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector t cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132
30. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-1141
31. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol. 2003;23:454-460
32. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFNgamma potentiates atherosclerosis in apoe knock-out mice. J Clin Invest. 1997;99:2752-2761
33. Whitman SC, Ravisankar P, Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein e-/- mice. J Interferon Cytokine Res. 2002;22:661-670
34. Whitman SC, Ravisankar P, Elam H, Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein e-/- mice. Am J Pathol. 2000;157:1819-1824
35. Fragale A, Gabriele L, Stellacci E, Borghi P, Perrotti E, Ilari R, et al. IFN regulatory factor-1 negatively regulates cd4+ cd25+ regulatory T cell differentiation by repressing foxp3 expression. J Immunol. 2008;181:1673-1682
36. Wessely R, Hengst L, Jaschke B, Wegener F, Richter T, Lupetti R, et al. A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia. Hum Mol Genet. 2003;12:177-187
37. Holvoet P, Davey PC, De Keyzer D, Doukoure M, Deridder E, Bochaton-Piallat ML, et al. Oxidized low-density lipoprotein correlates positively with toll-like receptor 2 and interferon regulatory factor-1 and inversely with superoxide dismutase-1 expression: studies in hypercholesterolemic swine and thp-1 cells. Arterioscler Thromb Vasc Biol. 2006;26:1558-1565
38. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, et al. An irf-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated t lymphocytes. Nature. 1995;376:596-599
39. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 1994;77:829-839
40. Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, Affabris E. IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res. 2002;22:39-47.
41. Kano S, Sato K, Morishita Y, Vollstedt S, Kim S, Bishop K, et al. The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and th1 versus th-17 differentiation of cd4+ T cells. Nat Immunol. 2008;9:34-41.